109 related articles for article (PubMed ID: 37548201)
21. Galectin 3 expression in primary oral squamous cell carcinomas.
Weber M; Büttner-Herold M; Distel L; Ries J; Moebius P; Preidl R; Geppert CI; Neukam FW; Wehrhan F
BMC Cancer; 2017 Dec; 17(1):906. PubMed ID: 29284429
[TBL] [Abstract][Full Text] [Related]
22. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
23. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
Liu Y; Li R; Ren G
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
[TBL] [Abstract][Full Text] [Related]
24. Oncological safety of submental island flap for reconstruction of pathologically node-negative and node-positive T1-2 oral squamous cell carcinoma-related defects: A retrospective study and comparison of outcomes.
Wang J; Tan Y; Shen Y; Lv M; Li J; Sun J
Oral Oncol; 2020 Mar; 102():104507. PubMed ID: 31896500
[TBL] [Abstract][Full Text] [Related]
25. The balance of serum IL-18/IL-37 levels is disrupted during the development of oral squamous cell carcinoma.
Ding L; Zhao X; Zhu N; Zhao M; Hu Q; Ni Y
Surg Oncol; 2020 Mar; 32():99-107. PubMed ID: 31983439
[TBL] [Abstract][Full Text] [Related]
26. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
[TBL] [Abstract][Full Text] [Related]
27. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
28. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of an inflammation scoring system in radical resection of oral squamous cell carcinoma.
Wu M; Ye P; Zhang W; Zhu H; Yu H
BMC Oral Health; 2022 Jun; 22(1):226. PubMed ID: 35676658
[TBL] [Abstract][Full Text] [Related]
30. Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma.
Pang X; Fan HY; Tang YL; Wang SS; Cao MX; Wang HF; Dai LL; Wang K; Yu XH; Wu JB; Tang YJ; Liang XH
PLoS One; 2020; 15(2):e0229089. PubMed ID: 32092078
[TBL] [Abstract][Full Text] [Related]
31. The relative propensity for regional metastasis in floor of mouth squamous cell carcinoma versus other oral cavity subsites.
Wicks C; Zubair F; Ogunbowale A; McMahon J
Br J Oral Maxillofac Surg; 2022 Nov; 60(9):1276-1278. PubMed ID: 36229310
[TBL] [Abstract][Full Text] [Related]
32. MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.
Yao LX; Liu J; Xu L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):187-197. PubMed ID: 30657560
[TBL] [Abstract][Full Text] [Related]
33. Detection of peripheral blood circulating tumor cells in oral squamous cell carcinoma and its clinical significance.
Zhang SY; Qin S; Li GH; Yi YQ; Fu HJ; Gao YJ; Sun ML
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Oct; 39(5):591-597. PubMed ID: 34636209
[TBL] [Abstract][Full Text] [Related]
34. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
[TBL] [Abstract][Full Text] [Related]
35. Hyperion Image Analysis Depicts a Preliminary Landscape of Tumor Immune Microenvironment in OSCC with Lymph Node Metastasis.
Xie S; Zhang XY; Shan XF; Yau V; Zhang JY; Wang W; Yan YP; Cai ZG
J Immunol Res; 2021; 2021():9975423. PubMed ID: 34239944
[TBL] [Abstract][Full Text] [Related]
36. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
37. Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.
Inoue K; Hatano K; Hanamatsu Y; Saigo C; Kito Y; Bunai K; Shibata T; Takeuchi T
J Cancer Res Clin Oncol; 2019 Apr; 145(4):851-859. PubMed ID: 30635792
[TBL] [Abstract][Full Text] [Related]
38. Expression of Kif5b protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma.
Luan YJ; Xu Y; Cai J; Dou Y; Yu WJ; Wang KT; Liu SH; Yang PS; Qu X; Wei FC
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4542-4550. PubMed ID: 30058692
[TBL] [Abstract][Full Text] [Related]
39. Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
Noda Y; Ishida M; Ueno Y; Fujisawa T; Iwai H; Tsuta K
BMC Cancer; 2022 Apr; 22(1):402. PubMed ID: 35418058
[TBL] [Abstract][Full Text] [Related]
40. [Application of near infrared fluorescence imaging in detection of residual cancer in oral squamous cell carcinoma].
Zhang Q; Xia CW; Hu SQ; Wang Y; Pu YM; Wang YX
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):450-454. PubMed ID: 35615804
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]